India looks for test kits from South Korea

South Korea is proving out to be an important source of medical supplies for India among the countries for novel coronavirus with aggressive testing and contact tracing. The Indian embassy in Seoul signed an agreement for supply of 5,00,000 rapid test kits from a South Korean company to the ICMR.

According to the agreement, the kits will be delivered in 4 separate consignments, the first of which will reach India April 30.

The procurement will help scale up the availability of tests which is a “big weapon’’ in the fight against Covid-19 said, India’s ambassador to South Korea Sripriya Ranganathan

“It’s not a buyer’s market but the goodwill which India enjoys with the South Korean government and its people has meant that the manufacturers are much more receptive to our needs and more flexible in meeting our demands.”

Ranganathan further added that, ‘all procurement is certified for export and subject to quality checks. “These have been found suitable for use by the ICMR. The company with which the embassy has signed the agreement is sourcing raw materials for production of the diagnostic testing kits from India, a collaboration described as a tribute to the special strategic partnership between the 2 countries.”

“It wasn’t that the Koreans from the start had the option of walking up to a hospital and getting themselves tested. It was also very expensive initially but they built up their capacity over a period of time by making tests available. Over 2 months, they pumped more tests into their healthcare system and spread the net wide as out agencies are doing now in India,’’ she said.

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy